Contribution of diacylglycerol lipase β to pain after surgery
Open Access
- 1 March 2018
- journal article
- research article
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 11, 473-482
Abstract
Background: Metabolism of the endocannabinoid 2-arachidonoylglycerol (2-AG) yields arachidonic acid (AA), the precursor to proalgesic eicosanoids including prostaglandin E2 (PGE2). Diacylglycerol lipase β (DAGLβ) is an enzyme that synthesizes 2-AG and its inhibition reduces eicosanoid levels and produces antinociceptive effects in models of inflammatory pain. Here we test whether inhibition of DAGLβ produces antinociceptive effects in a model of postoperative pain. Methods: Rats were administered the selective DAGLβ inhibitor KT109 or vehicle and underwent plantar incision. Postsurgical pain/disability was examined using evoked (mechanical hyperalgesia), functional (incapacitance/weight bearing), and functional/spontaneous (locomotion) modalities. Results: Activity-based protein profiling confirmed that KT109 inhibited DAGLβ in the lumbar spinal cord (LSC) and brain, confirming that it is a systemically active DAGLβ inhibitor. Treatment with KT109 reduced basal 2-AG, AA, and PGE2 levels in the liver but not the brain, indicating that DAGLβ activity does not significantly contribute to basal PGE2 production within the central nervous system. Plantar incision elevated the levels of 2-AG and PGE2 in the LSC. Although KT109 did not alter postsurgical 2-AG levels in the LSC, it slightly reduced PGE2 levels. In contrast, the clinically efficacious cyclooxygenase inhibitor ketoprofen completely suppressed PGE2 levels in the LSC. Similarly, KT109 had no significant effect upon postsurgical 2-AG, AA, or PGE2 levels at the incision site, while ketoprofen abolished PGE2 production at this location. KT109 and ketoprofen reversed the weight bearing imbalance induced by plantar incision, yet neither KT109 nor ketoprofen had any significant effect on mechanical hyperalgesia. Treatment with ketoprofen partially but significantly rescued the locomotor deficit induced by incision while KT109 was without effect. Conclusion: DAGLβ is not the principal enzyme that controls 2-AG derived AA and PGE2 production after surgery, and inhibitors targeting this enzyme are unlikely to be efficacious analgesics superior to those already approved to treat acute postoperative pain.Keywords
This publication has 49 references indexed in Scilit:
- Anxiety, Stress, and Fear Response in Mice With Reduced Endocannabinoid LevelsBiological Psychiatry, 2016
- Perioperative Opioids and Public HealthAnesthesiology, 2016
- A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammationeLife, 2016
- Development and Characterization of a Novel, Anatomically Relevant Rat Model of Acute Postoperative PainThe Journal of Pain, 2015
- Improving the translation of analgesic drugs to the clinic: animal models of neuropathic painBritish Journal of Pharmacology, 2014
- The fatty acid amide hydrolase (FAAH) inhibitor PF‐3845 acts in the nervous system to reverse LPS‐induced tactile allodynia in miceBritish Journal of Pharmacology, 2011
- A New Knee Surgery Model in Rats to Evaluate Functional Measures of Postoperative PainAnesthesia & Analgesia, 2008
- Nefopam and ketoprofen synergy in rodent models of antinociceptionEuropean Journal of Pharmacology, 2008
- Peripheral prostanoid levels and nonsteroidal anti‐inflammatory drug analgesia: Replicate clinical trials in a tissue injury modelClinical Pharmacology & Therapeutics, 2002
- Activity-based protein profiling: The serine hydrolasesProceedings of the National Academy of Sciences, 1999